Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06480929Not ApplicableCompleted

LV Thrombus Screening in Anterior STEMI: Worth it?

Role: lead

NCT04932421Not ApplicableCompleted

Unified Protocol for Children: A Randomized Controlled Trial for the Portuguese Population

Role: collaborator

NCT05414435Completed

Informed Consent in Endoscopy: Read, Understood or Merely Signed?

Role: lead

NCT05162339Completed

Inflammatory Bowel Disease and Thromboembolic Events

Role: lead

NCT05040854Unknown

Can we Rely on HLA to Predict Resistance to Biological Therapy in IBD Patients

Role: lead

NCT02543515Completed

Psychosocial and Clinical Characteristics Predicting Women's Acceptance of Office Hysteroscopy

Role: lead

All 6 trials loaded